ES2160688T3 - Procedimiento para obtener una preparacion de clodronato. - Google Patents
Procedimiento para obtener una preparacion de clodronato.Info
- Publication number
- ES2160688T3 ES2160688T3 ES95900155T ES95900155T ES2160688T3 ES 2160688 T3 ES2160688 T3 ES 2160688T3 ES 95900155 T ES95900155 T ES 95900155T ES 95900155 T ES95900155 T ES 95900155T ES 2160688 T3 ES2160688 T3 ES 2160688T3
- Authority
- ES
- Spain
- Prior art keywords
- clodronate
- disodic
- tetrahydrate
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ceramic Products (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Detergent Compositions (AREA)
- Glass Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Peptides Or Proteins (AREA)
- Seasonings (AREA)
- Glanulating (AREA)
Abstract
EL FIN DE LA INVENCION ES UN PROCEDIMIENTO PARA PREPARAR UNA PREPARACION DE CLODRONATO CUYO PROCEDIMIENTO SE CARACTERIZA PORQUE EL CLODRONATO SE CRISTALIZA A MODO DE TETRAHIDRATO DE CLODRONATO DISODICO A PARTIR DE UNA SOLUCION ACUOSA DE CLODRONATO DISODICO; EL TETRAHIDRATO DE CLODRONATO DISODICO RESULTANTE SE GRANULA EN SECO A BASE DE COMPRIMIRLO DE TAL MODO QUE SE MANTENGA LA ESTRUCTURA CRISTALINA DEL TETRAHIDRATO DE CLODRONATO DISODICO Y DE DESMENUZAR Y SEPARAR LA MASA HASTA OBTENER GRANULOS DE TAMAÑO ADECUADO; EL TETRAHIDRATO DE CLODRONATO DISODICO GRANULADO EN SECO SE MEZCLA OPCIONALMENTE CON EXCIPIENTES ADECUADOS, TALES COMO AGENTES DE RELLENO Y AGENTES DE PLANEO Y, EN CASO NECESARIO, DESINTEGRANTES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI935019A FI94926C (fi) | 1993-11-12 | 1993-11-12 | Menetelmä klodronaattivalmisteen valmistamiseksi |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2160688T3 true ES2160688T3 (es) | 2001-11-16 |
Family
ID=8538945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95900155T Expired - Lifetime ES2160688T3 (es) | 1993-11-12 | 1994-11-11 | Procedimiento para obtener una preparacion de clodronato. |
Country Status (25)
Country | Link |
---|---|
US (1) | US5776499A (es) |
EP (1) | EP0727983B1 (es) |
JP (1) | JPH09504800A (es) |
KR (1) | KR100352155B1 (es) |
CN (1) | CN1040945C (es) |
AT (1) | ATE202700T1 (es) |
AU (1) | AU679586B2 (es) |
CA (1) | CA2175994A1 (es) |
CZ (1) | CZ286132B6 (es) |
DE (1) | DE69427648T2 (es) |
DK (1) | DK0727983T3 (es) |
ES (1) | ES2160688T3 (es) |
FI (1) | FI94926C (es) |
GR (1) | GR3036470T3 (es) |
HU (1) | HU220633B1 (es) |
IL (1) | IL111596A (es) |
NO (1) | NO312938B1 (es) |
NZ (1) | NZ275833A (es) |
PL (1) | PL176658B1 (es) |
PT (1) | PT727983E (es) |
RU (1) | RU2141323C1 (es) |
SK (1) | SK280552B6 (es) |
TW (1) | TW436297B (es) |
WO (1) | WO1995013054A1 (es) |
ZA (1) | ZA948974B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI109088B (fi) * | 1997-09-19 | 2002-05-31 | Leiras Oy | Tabletti ja menetelmä sen valmistamiseksi |
DE19808634A1 (de) * | 1998-02-24 | 1999-08-26 | Schering Ag | Mantel für eine pharmazeutische Zusammensetzung |
AR021347A1 (es) * | 1999-10-20 | 2002-07-17 | Cipla Ltd | Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma |
RO121891B1 (ro) | 2001-07-04 | 2008-07-30 | Sindan S.R.L. | Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
KR102194944B1 (ko) * | 2015-12-22 | 2020-12-29 | 스탁 컴퍼니 “체펫스키 메커니컬 플랜트″(에스씨 씨엠피) | 티타늄계 합금으로부터 로드를 제조하는 방법 |
JP2021504339A (ja) | 2017-11-22 | 2021-02-15 | インバイオモーション エセ.エレ. | c−MAFの状態に基づく乳がんの治療的処置 |
TWI806467B (zh) | 2022-03-03 | 2023-06-21 | 金兆豐數位科技股份有限公司 | 金融商品提昇報酬率多維度決策方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2040733T3 (es) * | 1986-12-20 | 1993-11-01 | Boehringer Mannheim Gmbh | Medicamentos que contienen clodronato y procedimiento para su preparacion. |
SE501389C2 (sv) * | 1992-04-24 | 1995-01-30 | Leiras Oy | Farmaceutiskt preparat och förfarande för dess framställning |
US5650168A (en) | 1993-05-15 | 1997-07-22 | Boehringer Mannheim Gmbh | Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
-
1993
- 1993-11-12 FI FI935019A patent/FI94926C/fi not_active IP Right Cessation
-
1994
- 1994-11-10 IL IL11159694A patent/IL111596A/en active IP Right Grant
- 1994-11-11 NZ NZ275833A patent/NZ275833A/en unknown
- 1994-11-11 EP EP95900155A patent/EP0727983B1/en not_active Expired - Lifetime
- 1994-11-11 US US08/646,359 patent/US5776499A/en not_active Expired - Lifetime
- 1994-11-11 JP JP7513620A patent/JPH09504800A/ja not_active Ceased
- 1994-11-11 RU RU96113106A patent/RU2141323C1/ru not_active IP Right Cessation
- 1994-11-11 SK SK606-96A patent/SK280552B6/sk unknown
- 1994-11-11 PT PT95900155T patent/PT727983E/pt unknown
- 1994-11-11 AU AU81087/94A patent/AU679586B2/en not_active Ceased
- 1994-11-11 WO PCT/FI1994/000509 patent/WO1995013054A1/en active IP Right Grant
- 1994-11-11 ES ES95900155T patent/ES2160688T3/es not_active Expired - Lifetime
- 1994-11-11 HU HU9601257A patent/HU220633B1/hu not_active IP Right Cessation
- 1994-11-11 CZ CZ19961327A patent/CZ286132B6/cs not_active IP Right Cessation
- 1994-11-11 ZA ZA948974A patent/ZA948974B/xx unknown
- 1994-11-11 PL PL94314299A patent/PL176658B1/pl unknown
- 1994-11-11 CN CN94194083A patent/CN1040945C/zh not_active Expired - Fee Related
- 1994-11-11 AT AT95900155T patent/ATE202700T1/de not_active IP Right Cessation
- 1994-11-11 DE DE69427648T patent/DE69427648T2/de not_active Expired - Fee Related
- 1994-11-11 CA CA002175994A patent/CA2175994A1/en not_active Abandoned
- 1994-11-11 KR KR1019960702481A patent/KR100352155B1/ko not_active IP Right Cessation
- 1994-11-11 DK DK95900155T patent/DK0727983T3/da active
- 1994-11-17 TW TW083110664A patent/TW436297B/zh not_active IP Right Cessation
-
1996
- 1996-05-10 NO NO19961906A patent/NO312938B1/no unknown
-
2001
- 2001-08-30 GR GR20010401329T patent/GR3036470T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2160688T3 (es) | Procedimiento para obtener una preparacion de clodronato. | |
ES2529167T3 (es) | Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares | |
AR041831A1 (es) | Composicion de enlucido para relleno de juntas para elementos de construccion y procedimiento de realizacion de una obra | |
ES2088973T3 (es) | Cloracion mejorada de 6-esteres de sacarosa. | |
ES2180628T3 (es) | Proceso para preparar piritiona de cobre. | |
GT200000190A (es) | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas. | |
EA200200951A1 (ru) | Фармацевтические композиции | |
AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
ES2080401T3 (es) | Procedimiento para la preparacion de copoliesteres estadisticos. | |
ES2029467T3 (es) | Procedimiento para la obtencion de agentes en forma de bloque de fusion que contienen hidroxido alcalino y, dado el caso, tambien cloro activo para la limpieza mecanica de vajilla. | |
ES2062796T3 (es) | Procedimiento para producir un mejorador de detergencia aglomerado de 2,2'-oxodisuccinato y zeolita a. | |
JPS52110563A (en) | Hexagonal boride cathode | |
ES485842A0 (es) | Procedimiento para la obtencion de preparados de valepotria-tos en forma de microcapsulas. | |
ES2162324T3 (es) | Procedimiento de secado por pulverizacion para producir composiciones detergentes que implican premezclar polimeros de poliaminas modificadas. | |
ES2119450T3 (es) | Procedimiento para la obtencion de perlas y perlas obtenidas que contienen un principio activo que presenta un punto de fusion no definido. | |
DE69914327D1 (de) | Biologisch aktive mikrodispersionszusammensetzung | |
AR004490A1 (es) | Procedimiento para preparar compuestos biocidas de liberacion sostenida. | |
ES2138423T3 (es) | Procedimiento para la obtencion de polimeros sindiotacticos y parcialmente cristalinos a partir de monomeros vinilaromaticos. | |
AR247469A1 (es) | Preparacion de mezcla 1:1 de isomeros 1rcis s y 1scisr exenta de isomeros 1scis s y 1rcisr de derivados del 3-(2, 2-dihalovinil)-2, 2-dimetil-ciclopropano-carboxilato de alfa-ciano-3-fenoxibencilo | |
NO870950L (no) | Fremgangsmte for fremstilling av et stabilt injiserbart farmasytisk preparat. | |
JPS5437594A (en) | Semiconductor laser and its manufacture | |
JPS5420685A (en) | Light emitting diode | |
JPS52129394A (en) | X-ray generator | |
CO4520304A1 (es) | Dihidrato de eprosartano y un procedimiento para su produc- cion y formulacion | |
ES2061394B1 (es) | Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 727983 Country of ref document: ES |